Show items per page
Elements: 100
Page 4 on 5
 TitleAuthors / EditorsDate
add to browser selection
Long-term follow-up of the imatinib GRAAPH-2003 study in newly diagnosed patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: a GRAALL study Tanguy-Schmidt, Aline; Rousselot, Philippe; Chalandon, Yves; Cayuela, Jean-Michel; ... Thomas, Xavier 2013
add to browser selection
Longer intervals between hematopoietic stem cell transplantation and subsequent 90Y-ibritumomab radioimmunotherapy may correlate with better tolerance Buchegger, Franz; Prior, John O; Allenbach, Gilles; Baechler, Sébastien; ... Ketterer, Nicolas 2012
add to browser selection
Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis Girardin, François; Poncet, Antoine; Blondon, Marc; Rollason Gumprecht, Victoria; ... Combescure, Christophe 2014
add to browser selection
NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and Eomesodermin Simonetta, Federico; Pradier, Amandine; Bosshard, Carine; Masouridi-Levrat, Stavroula; ... Roosnek, Eddy Emile 2015
add to browser selection
Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison Baumgartner, Annic; Bargetzi, Mario; Bargetzi, Annika; Zueger, Noemi; ... Schuetz, Philipp 2017
add to browser selection
Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia Beldjord, Kheira; Chevret, Sylvie; Asnafi, Vahid; Huguet, Françoise; ... Dombret, Hervé 2014
add to browser selection
Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation Bieri, Sabine; Roosnek, Eddy Emile; Ozsahin, Ayse Hulya; Huguet-El Abkari, Saadia; ... Chalandon, Yves 2011
add to browser selection
Outcome of hematopoietic stem cell transplantation is similar for patients with a partial in vitro T-cell-depleted graft compared with a non-T-cell-depleted graft when stratified by the refined disease risk index Beauverd, Yan; Roosnek, Eddy Emile; Tirefort, Y; Dantin, C; ... Chalandon, Yves 2016
add to browser selection
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT Chalandon, Yves; Passweg, Jakob; Schmid, C.; Olavarria, E.; ... Guglielmi, C. 2010
add to browser selection
Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT. McLornan, Donal P; Szydlo, Richard; Robin, Marie-Claude; van Biezen, Anja; ... Kröger, Nicolaus 2018
add to browser selection
Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation Simonetta, Federico; Masouridi-Levrat, Stavroula; Beauverd, Yan; Tsopra, Olga; ... Chalandon, Yves 2017
add to browser selection
PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study Familiades, J; Bousquet, M; Lafage-Pochitaloff, M; Béné, M-C; ... Delabesse, E 2009
add to browser selection
Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study Ben Abdelali, Raouf; Asnafi, Vahid; Leguay, Thibaut; Boissel, Nicolas; ... Ifrah, Norbert 2011
add to browser selection
Post-artesunate delayed haemolysis ‒ report of four cases and review of the literature Boillat, Olivier; Spechbach, Hervé; Chalandon, Yves; Eperon, Gilles Alain 2015
add to browser selection
Prérequis nécessaires pour la mise en place de protocoles de recherche clinique évaluant des thérapies cellulaires et géniques par lymphocytes T dotés de récepteur chimérique à l’antigène (CAR T-cells) Yakoub-Agha, Ibrahim; Ferrand, Christophe; Chalandon, Yves; Ballot, Caroline; ... Chabannon, Christian 2017
add to browser selection
Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications Chalandon, Yves; Degermann, Sylvie; Villard, Jean; Arlettaz, Lionel; ... Roosnek, Eddy Emile 2006
add to browser selection
Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation Chalandon, Yves; Roosnek, Eddy Emile; Mermillod, Bernadette; Newton, Anita Marie; ... Chapuis, Bernard 2004
add to browser selection
Quality of life and social integration after allogeneic hematopoietic SCT Bieri, Stefan; Roosnek, Eddy Emile; Helg, C.; Verholen, F.; ... Chalandon, Yves 2008
add to browser selection
Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patients Buchegger, Franz; Larson, Steven M; Mach, Jean-Pierre; Chalandon, Yves; ... Speiser, Daniel E 2013
add to browser selection
Reconstitution of the immune system after hematopoietic stem cell transplantation in humans Storek, Jan; Geddes, Michelle; Khan, Faisal; Huard, Bertrand; ... Roosnek, Eddy Emile 2008
| 1 | 2 | 3 | 4 | 5 |